Mirae Asset Global Etfs Holdings Ltd. Rhythm Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 32,351 shares of RYTM stock, worth $3.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,351
Previous 35,282
8.31%
Holding current value
$3.2 Million
Previous $1.87 Million
9.42%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RYTM
# of Institutions
246Shares Held
64MCall Options Held
210KPut Options Held
575K-
Black Rock Inc. New York, NY6.74MShares$668 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$555 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.56MShares$551 Million7.68% of portfolio
-
Primecap Management CO Pasadena, CA4.88MShares$483 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$355 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.52B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...